Expert Review of Neurotherapeutics

Papers
(The H4-Index of Expert Review of Neurotherapeutics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Where Art Thou O treatment for diabetic neuropathy: the sequel49
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men49
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?43
The relevance of cortical thickness in migraine sufferers and implications to therapy42
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 202531
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options30
Steps to manage treatment-refractory migraine in adults30
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis30
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives29
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms29
Advances in the treatment and management of frontotemporal dementia28
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?28
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study27
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease26
The latest developments with internet-based psychological treatments for depression26
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review25
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents25
Why is ADHD so difficult to diagnose in older adults?24
The value and risks of antidepressant therapy in Alzheimer’s disease: a field update and its clinical implications24
Acute and long-term cognitive impairment following sepsis: mechanism and prevention23
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead23
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia23
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?22
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor22
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations22
Hesitancies in primary headaches treatments22
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan22
0.11695218086243